SCHEMBL333882

SCHEMBL333882

Cn1nccc1-c1ncc(Br)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
MALT1 Q9UDY8 1/20 0.41
COMT P21964 1/20 0.40
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.35
S1PR1 P21453 1/20 0.34
PLAU P00749 1/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP19A1 P11511 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KCNH2 Q12809 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
METAP2 P50579 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17293168 0.81 ALDH1A1 (0.43) ALDH1A1MAPTMALT1COMTS1PR1
SCHEMBL17293158 0.81 ALDH1A1 (0.43) ALDH1A1MAPTMALT1COMTS1PR1
SCHEMBL21030730 0.79 MALT1 (0.46) ALDH1A1MAPTMALT1COMTSMN1; SMN2
SCHEMBL21030631 0.79 ALDH1A1 (0.41) ALDH1A1MAPTMALT1COMTS1PR1
SCHEMBL23495764 0.77 CYP1A2 (0.37) COMTGABRG2GABRB3GABRA5SMN1; SMN2
SCHEMBL17293038 0.77 MALT1 (0.42) ALDH1A1MAPTMALT1COMTSMN1; SMN2
SCHEMBL18820154 0.76 MALT1 (0.42) ALDH1A1MAPTMALT1COMTS1PR1
SCHEMBL332643 0.74 ALDH1A1 (0.53) ALDH1A1MAPTCOMTGABRG2GABRB3
SCHEMBL333926 0.73 KMT2A (0.41) ALDH1A1MAPTSMN1; SMN2S1PR1PLAU
SCHEMBL21858874 0.72 ALDH1A1 (0.46) ALDH1A1MAPTMALT1COMTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387964-A1 HETEROARYLAMINOQUINOLINES AND ANALOGUES BAYER AKTIENGESELLSCHAFT (DE) 2021-12-16 US disclosed
WO-2020079167-A1 HETEROARYLAMINOQUINOLINES AND ANALOGUES BAYER AKTIENGESELLSCHAFT (DE) 2020-04-23 WO disclosed
US-8097733-B2 Pyrazole derivatives as 5-LO-inhibitors PFIZER INC. (US) 2012-01-17 US disclosed
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors PFIZER INC. 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors ALOX5, ALOX15, CYP3A5 ALDH1A1 224/4885MAPT 4364/4885MALT1 2368/4885
US-20210387964-A1 HETEROARYLAMINOQUINOLINES AND ANALOGUES PIK3C3, ERG28, CBR3 ALDH1A1 2522/4885MAPT 3418/4885MALT1 2970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.